- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
sanofi-aventis
(NYSE:SNY)Key Stats & Ratios
| Valuation | |
| Market Cap | 84.58B |
| P/E | 14.10 |
| P/E (Trailing) | 14.18 |
| P/E (Forward) | — |
| Price/Sales | 1.91 |
| Price/Book | 1.32 |
| EPS | 2.28 |
| EPS Growth (ttm) | 6.00% |
| Fiscal Year | |
| Fiscal Year Ends | Dec 31 |
| Last Quarter | Dec 2007 |
| Profitability | |
| Operating Income | 2.33B |
| Net Income | 7.56B |
| Profit Margin (ttm) | 16.90% |
| Operating Margin (ttm) | 0.07% |
| Management Effectiveness | |
| Return on Assets (ttm) | 7.10% |
| Return on Equity (ttm) | 11.60% |
| EBIT Margin (ttm) | 21.80 |
Financials
| Income Statement | |
| Total Enterprise Value | 94.70B |
| Revenue | 32.33B |
| Revenue/Share | 17.08 |
| Revenue Growth (ytd) | 12.70% |
| Annual Revenue Growth Rate (3Y) | 10.12% |
| Annual Income Growth Rate (3Y) | — |
| Earnings Growth (ytd) | 2.00% |
| Gross Operating Profit (ttm) | 29.93B |
| EBITDA | 25.40B |
| Diluted EPS (ttm) | 2.28 |
| Balance Sheet | |
| Total Cash | 1.50B |
| Total Cash/Share | 0.57 |
| Total Assets | 106.33B |
| Total Liabilities | 41.20B |
| Total Debt/Equity | — |
| Long Term Debt Common Equity Ratio | 0.10 |
| Current Ratio | 1.00 |
| Leverage Ratio | 1.00 |
| Book Value/Share | 24.79 |
| Cash Flow | |
| Cash Flow | 14.50B |
| Free Cash Flow | -402000000.00 |
| Cash Flow/Share | 5.31 |
| Free Cash Flow/Share | -0.15 |
Trading Information
| Stock Price History | |
| Beta | — |
| 52Wk Change | -33.20% |
| 52Wk Change Vs. Mkt | 3.00% |
| 52Wk High | 49.04 |
| 52Wk Low | 23.95 |
| 10 Day Moving Average | 31.72 |
| 200 Day Moving Average | 33.84 |
| Share Statistics | |
| Average Volume | 1.55M |
| Shares Outstanding | 2.63B |
| Shares Float | — |
| % Held by Insiders | — |
| % Held by Institutions | 7.40% |
| Shares Short (As of Dec 10, 2008) | 1.03M |
| Short Ratio | 0.60 |
| Short % of Float | — |
| Dividends & Splits | |
| Dividend Date | — |
| Dividend Yield | 5.00% |
| Dividend Amount | 1.62 |